Md Sakib

The World Health Organization (WHO) gave the nod to two new COVID-19 treatments. The news comes as Omicron cases have led to a spike in infections across the world. The WHO predicts that half of Europe will be infected with the virus by March. The WHO added that the arthritis drug 'baricitinib', when used with corticosteroids to treat severe or critical COVID patients, showed better survival rates and reduced the need for ventilators. In their recommendation in The BMJ, WHO experts recommended synthetic antibody treatment 'sotrovimab' for people with non-serious COVID, at the highest risk of hospitalisation, such as the elderly, and people with chronic diseases like diabetes. Since the outbreak began in China in December 2019, the coronavirus has killed at least 5,540,918 people worldwide. To combat the spread of the extremely infectious Omicron virus, countries are banning international flights and schools are closing across the globe. Meanwhile, British researchers found that toddlers and babies are more likely than older children to be hospitalized with Omicron, while the cases are still mild.